Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2026-02-26 @ 10:27 AM
Study NCT ID:
NCT00068692
Status:
COMPLETED
Last Update Posted:
2018-12-04
First Post:
2003-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rectal Mucinous Adenocarcinoma | View |
| None | Rectal Signet Ring Cell Adenocarcinoma | View |
| None | Recurrent Rectal Carcinoma | View |
| None | Stage IIA Rectal Cancer AJCC v7 | View |
| None | Stage IIB Rectal Cancer AJCC v7 | View |
| None | Stage IIC Rectal Cancer AJCC v7 | View |
| None | Stage IIIA Rectal Cancer AJCC v7 | View |
| None | Stage IIIB Rectal Cancer AJCC v7 | View |
| None | Stage IIIC Rectal Cancer AJCC v7 | View |
| None | Stage IVA Rectal Cancer AJCC v7 | View |
| None | Stage IVB Rectal Cancer AJCC v7 | View |